Transmissible cancers - cancers which can spread between individuals by the transfer of living cancer cells - are believed to arise extremely rarely in nature.
One of the few known transmissible cancers causes facial tumours in Tasmanian devils, and is threatening this species with extinction.
The discovery by researchers from the University of Tasmania in Australia, and the University of Cambridge in UK, calls into question our current understanding of the processes that drive cancers to become transmissible.
In 1996, researchers observed Tasmanian devils in the north-east of the island with tumours affecting the face and mouth; soon it was discovered that these tumours were contagious between devils, spread by biting.
The cancer spreads rapidly throughout the animal's body and the disease usually causes the death of affected animals within months of the appearance of symptoms.
The cancer has since spread through most of Tasmania and has triggered widespread devil population declines.
Cancer normally occurs when cells in the body start to proliferate uncontrollably. However, cancers do not usually survive beyond the body of the host from whose cells they originally derived.
"The second cancer causes tumours on the face that are outwardly indistinguishable from the previously-discovered cancer," said first author Ruth Pye, from the University of Tasmania.
"So far it has been detected in eight devils in the south-east of Tasmania," Pye said.
"Until now, we've always thought that transmissible cancers arise extremely rarely in nature, but this new discovery makes us question this belief," said senior author Elizabeth Murchison from the University of Cambridge.
Although this animal's tumours were outwardly very similar to those caused by the first-described Tasmanian devil transmissible cancer, the scientists found that this devil's cancer carried different chromosomal rearrangements and was genetically distinct.
Since then, eight additional animals have been found with the new cancer in the same area of south-east Tasmania.
"But, in other towns or small cities, due to limited
doctors and experts, they do not have such facility. These doctors can present the case of the patient before the experts all across the country and seek their opinion. To bridge such gap, we as a part of National Cancer Grid, felt that we should offer a group of experts can get together and opine," he said.
"100 to 120 people are participating at any time in the VTB. Currently, some 26 centres are active and soon all the 96 centres that are linked with VTB will start participating in it.
"We are increasing by 4-5 centres every week. We would like to make the VTB meetings daily. With all the 96 centres getting actively participative, we will be able to do discussions daily," he added.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
